Literature DB >> 16434428

Meal induced rectosigmoid tone modification: a low caloric meal accurately separates functional and organic gastrointestinal disease patients.

M Di Stefano1, E Miceli, A Missanelli, S Mazzocchi, G R Corazza.   

Abstract

BACKGROUND AND AIMS: Diagnosis of irritable bowel syndrome (IBS) is based on arbitrary criteria due to the lack of an accurate diagnostic test. The aim of this study was to evaluate whether rectosigmoid tone modification after a meal represents an accurate diagnostic approach.
METHODS: In a secondary care setting, 32 constipation predominant and 24 diarrhoea predominant IBS patients, 10 functional diarrhoea and 10 functional constipation patients, 29 organic gastrointestinal disease patients, and 10 healthy volunteers underwent a rectal barostat test to measure fasting and postprandial rectosigmoid tone. Rectosigmoid response was assessed following three meals containing different amounts of calories: 200 kcal, 400 kcal and 1000 kcal.
RESULTS: After 200 kcal, healthy volunteers and patients with organic diseases showed a reduction in rectosigmoid volume of at least 28% of fasting volume, indicating a meal induced increase in muscle tone. In contrast, patients with diarrhoea predominant IBS showed dilation of the rectosigmoid colon, indicative of reduced tone, and patients with constipation predominant IBS showed a mild volume reduction or no modification. Functional diarrhoea and constipation patients showed rectosigmoid tone modification resembling that of the corresponding IBS subtype. A 400 kcal meal normalised rectosigmoid tone in more than half of the constipation predominant IBS patients but none of the diarrhoea predominant IBS patients. In contrast, a 1000 kcal meal normalised tone response in all IBS patients. Sensitivity of the test was 100%, specificity 93%, positive predictive value 96%, and negative predictive value 100%.
CONCLUSION: A postprandial reduction in rectosigmoid tone of at least 28% of fasting value after a low caloric meal accurately separates organic and functional gastrointestinal disease patients. This parameter may therefore be used in the positive diagnosis of IBS.

Entities:  

Mesh:

Year:  2006        PMID: 16434428      PMCID: PMC1856407          DOI: 10.1136/gut.2005.076323

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  33 in total

1.  Tegaserod, a 5-HT(4) receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation.

Authors:  S A Müller-Lissner; I Fumagalli; K D Bardhan; F Pace; E Pecher; B Nault; P Rüegg
Journal:  Aliment Pharmacol Ther       Date:  2001-10       Impact factor: 8.171

Review 2.  Do we need to perform rectal distention tests to diagnose IBS in clinical practice?

Authors:  Michel Delvaux
Journal:  Gastroenterology       Date:  2002-06       Impact factor: 22.682

3.  Rectal hyposensitivity: a disorder of the rectal wall or the afferent pathway? An assessment using the barostat.

Authors:  Marc A Gladman; Lee S Dvorkin; Peter J Lunniss; Norman S Williams; S Mark Scott
Journal:  Am J Gastroenterol       Date:  2005-01       Impact factor: 10.864

Review 4.  Serotoninergic neuroenteric modulators.

Authors:  N J Talley
Journal:  Lancet       Date:  2001-12-15       Impact factor: 79.321

5.  Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial.

Authors:  M Camilleri; A R Northcutt; S Kong; G E Dukes; D McSorley; A W Mangel
Journal:  Lancet       Date:  2000-03-25       Impact factor: 79.321

6.  Effects of alosetron on spontaneous migrating motor complexes in murine small and large bowel in vitro.

Authors:  T G Bush; N J Spencer; N Watters; K M Sanders; T K Smith
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2001-10       Impact factor: 4.052

7.  Alosetron controls bowel urgency and provides global symptom improvement in women with diarrhea-predominant irritable bowel syndrome.

Authors:  T Lembo; R A Wright; B Bagby; C Decker; S Gordon; P Jhingran; E Carter
Journal:  Am J Gastroenterol       Date:  2001-09       Impact factor: 10.864

8.  Rectal distention testing in patients with irritable bowel syndrome: sensitivity, specificity, and predictive values of pain sensory thresholds.

Authors:  Mickael Bouin; Victor Plourde; Michel Boivin; Monique Riberdy; France Lupien; Marie Laganière; Pierre Verrier; Pierre Poitras
Journal:  Gastroenterology       Date:  2002-06       Impact factor: 22.682

9.  A randomized, double-blind, placebo-controlled trial of tegaserod in female patients suffering from irritable bowel syndrome with constipation.

Authors:  J Novick; P Miner; R Krause; K Glebas; H Bliesath; G Ligozio; P Rüegg; M Lefkowitz
Journal:  Aliment Pharmacol Ther       Date:  2002-11       Impact factor: 8.171

10.  Compliance, tone and sensitivity of the rectum in different subtypes of irritable bowel syndrome.

Authors:  J Steens; P J Van Der Schaar; C Penning; J Brussee; A A M Masclee
Journal:  Neurogastroenterol Motil       Date:  2002-06       Impact factor: 3.598

View more
  14 in total

1.  Lack of an Effect of Gastric Capsaicin on the Rectal Component of the Gastrocolonic Response.

Authors:  Martina Führer; Johann Hammer
Journal:  Dig Dis Sci       Date:  2017-10-30       Impact factor: 3.199

Review 2.  Inflammation in irritable bowel syndrome: Myth or new treatment target?

Authors:  Emanuele Sinagra; Giancarlo Pompei; Giovanni Tomasello; Francesco Cappello; Gaetano Cristian Morreale; Georgios Amvrosiadis; Francesca Rossi; Attilio Ignazio Lo Monte; Aroldo Gabriele Rizzo; Dario Raimondo
Journal:  World J Gastroenterol       Date:  2016-02-21       Impact factor: 5.742

Review 3.  Gut Movements: A Review of the Physiology of Gastrointestinal Transit.

Authors:  Dennis Kumral; Alvin M Zfass
Journal:  Dig Dis Sci       Date:  2018-10       Impact factor: 3.199

Review 4.  Functional findings in irritable bowel syndrome.

Authors:  Iris Posserud; Amanda Ersryd; Magnus Simrén
Journal:  World J Gastroenterol       Date:  2006-05-14       Impact factor: 5.742

Review 5.  Is irritable bowel syndrome an organic disorder?

Authors:  Magdy El-Salhy; Doris Gundersen; Odd Helge Gilja; Jan Gunnar Hatlebakk; Trygve Hausken
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

6.  Effect of meal ingestion on ileocolonic and colonic transit in health and irritable bowel syndrome.

Authors:  Annemie Deiteren; Michael Camilleri; Duane Burton; Sanna McKinzie; Archana Rao; Alan R Zinsmeister
Journal:  Dig Dis Sci       Date:  2010-02       Impact factor: 3.199

Review 7.  Irritable bowel syndrome: a disease still searching for pathogenesis, diagnosis and therapy.

Authors:  Massimo Bellini; Dario Gambaccini; Cristina Stasi; Maria Teresa Urbano; Santino Marchi; Paolo Usai-Satta
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

8.  Contributions of pain sensitivity and colonic motility to IBS symptom severity and predominant bowel habits.

Authors:  Motoyori Kanazawa; Olafur S Palsson; Syed I M Thiwan; Marsha J Turner; Miranda A L van Tilburg; Lisa M Gangarosa; Denesh K Chitkara; Shin Fukudo; Douglas A Drossman; William E Whitehead
Journal:  Am J Gastroenterol       Date:  2008-08-05       Impact factor: 10.864

9.  Symptom pattern following a meal challenge test in patients with irritable bowel syndrome and healthy controls.

Authors:  Iris Posserud; Hans Strid; Stine Störsrud; Hans Törnblom; Ulla Svensson; Jan Tack; Lukas Van Oudenhove; Magnus Simrén
Journal:  United European Gastroenterol J       Date:  2013-10       Impact factor: 4.623

10.  Rectal visceral sensitivity in women with irritable bowel syndrome without psychiatric comorbidity compared with healthy volunteers.

Authors:  Signe Spetalen; Leiv Sandvik; Svein Blomhoff; Morten B Jacobsen
Journal:  Gastroenterol Res Pract       Date:  2009-09-17       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.